Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas: Guideline From the College of American Pathologists in Collaboration With the American Association of Neuropathologists, Association for Molecular Pathology, and Society for Neuro-Oncology
- MeSH Terms
In Situ Hybridization; Fluorescence (E05.393.285.350); Comparative Genomic Hybridization (E05.393.285.240); Molecular Probe Techniques (E05.601); Brain Neoplasms (C04.588.614.250.195); Diagnosis (E01); Genetic Testing (E05.200.562); Histological Techniques (E05.200.750); Histocytological Preparation Techniques (E05.200.750.600); Immunohistochemistry (E05.200.750.551.512); Molecular Diagnostic Techniques (E05.200.880); Biopsy (E05.200.998.054); Genetic Techniques (E05.393)
- Guideline Contact
- Nicole Thomas ([email protected])
- Keywords
- Diffuse gliomas, dg, molecular testing
- Publication Date
- 17-Feb-22
- Publication Scope
- assessment
- prognosis
- Guideline Publication Status
- Published
- Languages
- English
- Authors
- CAP (US)
- Publication Year
- 2022